Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2004
09/30/2004WO2004024768A3 Cytokine production-inducing antibody
09/30/2004WO2004021857A3 Method for retrospective birth dating of biomolecules, cells, tissues, organs and organisms
09/30/2004WO2004020917A3 Method for identifying thawed and refrozen products
09/30/2004WO2004018621A3 Method for determining gene knockout strategies
09/30/2004WO2004017049A3 Capillary rheometer
09/30/2004WO2004013608A3 Methods for eliminating false data from comparative data matrices and for quantifying data matrix quality
09/30/2004WO2003101278A3 Device and method of use for detection and characterization of pathogens and biological materials
09/30/2004WO2003098182A3 Method for quantifying molecules
09/30/2004WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
09/30/2004WO2003074739A3 Automated allele determination using fluorometric genotyping
09/30/2004WO2003072740A3 Novel type-1 cytokine receptor glm-r
09/30/2004WO2003065976A3 Microfluidics apparatus and methods of use therefor
09/30/2004WO2003051311A3 Antibody inhibiting stem cell factor activity and use for treatment of asthma
09/30/2004WO2003049530A3 Method and apparatus for washing magnetically responsive particles
09/30/2004WO2003036410A3 Treatment protocol generation for diseases related to angiogenesis
09/30/2004WO2003036299A8 Procedure for quantitative determination of viral or bacterial particles having a cholesterol-containing envelope
09/30/2004WO2003031930A3 A phosphatase associated with metastasis
09/30/2004WO2003014323A3 Human smooth muscle myosin heavy chain
09/30/2004WO2002086062A3 Methods of screening for compounds that modulate hormone receptor activity
09/30/2004US20040194158 Model for neurodegenerative disorders
09/30/2004US20040194157 Animal with surgically modified gastrointestinal tract and method for study of weight reduction
09/30/2004US20040193446 System and method for managing a patient treatment program including a prescribed drug regimen
09/30/2004US20040193379 Method of monitoring the operation of gas sensor and system therefor
09/30/2004US20040193375 Determining fluid properties from fluid analyzer
09/30/2004US20040193219 Extraction device, analyzer, extraction method, and analysis method
09/30/2004US20040193030 Body fluid collection and analysis
09/30/2004US20040193019 Methods for predicting an individual's clinical treatment outcome from sampling a group of patient's biological profiles
09/30/2004US20040192903 Comprises chromosomal regoin which codes pathogenicity islands (PAIs) for use in developing antibodies to detect and prevent bacterial infection; bactericides
09/30/2004US20040192901 Using superoxide dismutase to identify modulators for treatment of diabetes, scrapies, transmissible spongiform encephalopathies and alzheimer's diseases
09/30/2004US20040192898 Anti-abeta antibodies
09/30/2004US20040192893 comprises cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes for use in labeling nucleic acids or proteins in assay, and as diagnostic aid in genomics/proteomics
09/30/2004US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents
09/30/2004US20040192776 Cationic lipid compositions targeting angiogenic endothelial cells
09/30/2004US20040192663 measuring catalytic iron content in urine in a human afflicted with a progressive kidney disease and administering an iron chelator such as deferiprone; method can include measuring total urinary protein content, blood urea nitrogen, or creatinine
09/30/2004US20040192645 detecting chitin in mammals; useful for diagnosing disease caused by accumulation of chitin or amyloid plaques such as Alzheimer's disease, spongiform encepalopathies, type II diabetes, atrial amyloidosis; administering the composition to inhibit polymerization of N-acetylglucosamine to chitin
09/30/2004US20040192634 detecting anti-angiotensin II type 1 (AT1) receptor auto-antibodies in biological materials (body fluids or tissues) by an immune reaction with the AT1 receptor or functionally analogous peptides or proteins
09/30/2004US20040192604 Method and device for treating a protein deficiency
09/30/2004US20040192601 Lipid binding molecules and methods of use
09/30/2004US20040192597 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
09/30/2004US20040192591 Composition for treating Chlamydia infections and method for identifying same
09/30/2004US20040191926 Ptp1b inhibitors and ligands
09/30/2004US20040191925 Automatic analysis apparatus
09/30/2004US20040191923 Apparatus comprising guide for positioning probes; desktop analyzers for use in veterinary and point of care human diagnostics
09/30/2004US20040191922 Apparatus for coupled adsorption, desorption and ionization of multiple or selected analytes into gas (vapor) phase for use with mass spectrometry of biomolecules and macromolecules
09/30/2004US20040191918 Evaluation of bitterness of active drugs
09/30/2004US20040191916 electrospray ionization tandem mass spectrometry as diagnostic tool in monitoring lipid accumulation in blood for diagnosing stroke, athersclerosis and coronary artery diseases; bioinformatics
09/30/2004US20040191915 Determining orientation of photoactive moiety exhibiting anisotropic transition dipole via exposing moiety to light source, stimulating spectral emission and correlating emission with spacial positioning of moiety
09/30/2004US20040191913 Method of evaluation of antioxidation ability by measuring redox balance in vivo
09/30/2004US20040191891 Microwell biochip
09/30/2004US20040191889 See through testing device
09/30/2004US20040191884 Photoprotein derived from okinawan squid and gene encoding the photoprotein
09/30/2004US20040191853 Cellular physiology workstations for automated data acquisition and perfusion control
09/30/2004US20040191851 Methods for the identification of inhibitors of lipid transfer protein activity in plants
09/30/2004US20040191850 Nucleic acid molecules encoding proteins essential for plant growth and development and uses thereof
09/30/2004US20040191848 Arrangement for determinig the concentration of glucose in a body fluid
09/30/2004US20040191847 Kit for diagnosing gaucher disease in humans and animals
09/30/2004US20040191846 2,4,5-Trichlorophenoxyalkyl carboxylic acid and a method for determining dioxins using the same
09/30/2004US20040191844 Fluorescent dyes for intracellular detection of enzyme activity associated with apoptosis
09/30/2004US20040191843 Cytotoxic mixture comprising polypeptides for treatment and prevention of cell proliferfative disorders
09/30/2004US20040191842 Chemopreventive and therapeutic aspects of polyphenolic compositions and assays
09/30/2004US20040191841 Method for identification of cellular protein antigens and presence of antibodies to specific cellular protein antigens in serum
09/30/2004US20040191840 Using immunoglobulins to inactivate viricidal and antitumor activities of huma n type interferon for preventing autoimmunity and graft rejection; immunosuppressants
09/30/2004US20040191839 Methods for sorting undifferentiated cells and uses thereof
09/30/2004US20040191837 Method for detecting cells
09/30/2004US20040191836 Screening assay for agents that alter target of rapamycin activity
09/30/2004US20040191835 Screening method for identifying ligands for target proteins
09/30/2004US20040191834 Novel method
09/30/2004US20040191833 Selective activation of cellular activities mediated through a common toll-like receptor
09/30/2004US20040191832 Avidin derivatives and uses thereof
09/30/2004US20040191831 Enhancing immunodiagnostics via activated surface immobilizes antigen through covalent bonding by thermochemical reaction
09/30/2004US20040191829 Comprises peptide associated with sugar transport protein for identifying modulators for treatment and prevention of cell proliferative disorder
09/30/2004US20040191819 Expression profiles for breast cancer and methods of use
09/30/2004US20040191815 Array having oligonucleotides on a metal substrate
09/30/2004US20040191811 Methods for measuring levels of uridine-diphosphate-N-acetylglucosamine and activity of inhibitors thereof
09/30/2004US20040191809 Methods for registration at the nanometer scale
09/30/2004US20040191806 Assays using crosslinkable immobilized nucleic acids
09/30/2004US20040191805 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment
09/30/2004US20040191795 Rapid serological test for paratuberculosis using fluorescence polarization technology
09/30/2004US20040191794 Method for the determination of multiple analytes
09/30/2004US20040191793 Immunoassay for detecting an antigen-antibody reaction using polarized fluorescent light; biosensor for detection of microorganisms, viruses and biopolymers
09/30/2004US20040191792 Acridone derivatives as labels for fluorescence detection of target materials
09/30/2004US20040191791 Comprises nucleotide sequences coding sodium voltage gated channels for identifying modulators for treatment of epilepsy; diagnosis of seizure disorders
09/30/2004US20040191789 Using multicompartment device to screen pharmaceutical compounds and manipulate particles utilizing dielectrophoretic forces; diagnostic assay for agrifood analysis
09/30/2004US20040191786 Three cube fret method (3-fret) for detecting fluorescence energy transfer
09/30/2004US20040191785 Methods for diagnosing individuals with an increased risk to develop a deficiency based on mdr1 gene polymorphism
09/30/2004US20040191782 Evaluating colon tumors for recurrence via differential gene expression of tumor antigen genes in bowel cell walls; cancer diagnosis and treatments; antitumor agents
09/30/2004US20040191781 Genomic profiling of regulatory factor binding sites
09/30/2004US20040191779 Statistical analysis of regulatory factor binding sites of differentially expressed genes
09/30/2004US20040191778 Colloidal silver-biomolecule complexes
09/30/2004US20040191777 Apparatus and methods for isolating droplet dispensing devices
09/30/2004US20040191775 Methods of analyzing genes affected by caloric restriction or caloric restriction mimetics
09/30/2004US20040191770 Biological particulate matter analogue
09/30/2004US20040191766 Using fusion protein comprised of terminal reporter molecules to detect virusbinding and entry into cells; receptor-dependent targeted therapy; viricides
09/30/2004US20040191765 Label-free evanescent-field detection of biological and chemical agents
09/30/2004US20040191760 Lateral flow rapid immunoassay test device
09/30/2004US20040191757 High throughput method and system for screening candidate compounds for activity against target ion channels
09/30/2004US20040191756 Transgenic rodent for diagnosing and identifying modulator for treatment and prevention inflammatory disorders
09/30/2004US20040191320 Pulmonary formulation
09/30/2004US20040191249 Exposing tumor to ionizing radiation; administering drug library; isolating binding drug; cancer diagnosis; drug screening
09/30/2004US20040191245 Depleting sample of major histocompatibility complex (MHC) antibodies by contacting with genetically engineered MHC molecules, variants, or fragments attached to solid support and removal